Browse Content

Page 10 of 99
Sort by:
You must be signed in to view content.

Good to the Last Drop: Optimizing Biologic Therapy in IBD

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Calculate appropriate dosing regimens for biologic therapy.

Presenter: Fernando S. Velayos, MD, MPH

Release Date: 1/21/2016

Event: 2015 ACG Annual Meeting

CME Value: 0 minutes

Keywords: IBD, inflammatory bowel disease, biologics

Generic Anti-tumor Necrosis Factor Therapy: Biosimilars - Saints or Sinners?

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Assess the impact of biosimilars on treatment regimens.

Presenter: Gary R. Lichtenstein, MD, FACG

Release Date: 1/21/2016

Event: 2015 ACG Annual Meeting

CME Value: 0 minutes

Keywords: IBD, inflammatory bowel disease, biologics, anti-TNF, anti-tumor necrosis factor

What You Need to Know About Employment Law

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Identify possible legal complications in the workplace.

Presenter: Scott M. Tenner, MD, MPH, JD, FACG

Release Date: 1/21/2016

Event: 2015 ACG Annual Meeting

CME Value: 0 minutes

Keywords: practice management, law, employment, legal

The Chicago Classification: What Is Changing and How Does it Affect Clinical Practice?

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Summarize the newest version of the Chicago classification for esophageal motility tracings and the clinical implications of the new classification.

Presenter: Peter J. Kahrilas, MD, FACG

Release Date: 1/21/2016

Event: 2015 ACG Annual Meeting

CME Value: 0 minutes

Keywords: esophagus, motility, Chicago classification

Tools to Choose the Right Treatment Option (to Inject, to Bag or to Cut), to Assess Response, and Predict Outcomes in the Achalasia Patient

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Identify the manometric criteria (based on the Chicago classification) used to (a) decide the best treatment options, (b) assess response and (c) predict clinical outcomes in patients with achalasia.

Presenter: John E. Pandolfino, MD, MSCI, FACG

Release Date: 1/21/2016

Event: 2015 ACG Annual Meeting

CME Value: 0 minutes

Keywords: achalasia, esophagus

Therapeutic Options for the Non-Achalasia (Hypercontractile/Hypocontractile) Patient With Esophageal Motility Disorders

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Outline the treatments available for esophageal motility disorders other than achalasia.

Presenter: Marcelo F. Vela, MD, MSCR, FACG

Release Date: 1/21/2016

Event: 2015 ACG Annual Meeting

CME Value: 0 minutes

Sleep Effect on GI Health and Disease: Eyes Wide Open?

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Interpret the data on sleep effects on gastrointestinal health and disease.

Presenter: David A. Johnson, MD, MACG

Release Date: 1/21/2016

Event: 2015 ACG Annual Meeting

CME Value: 0 minutes

Keywords: sleep, GI health

Probiotics and Antibiotics: Are These First-Line Agents?

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Evaluate the clinical efficacy and safety of probiotics and antibiotics in IBS patients.

Presenter: Mark Pimentel, MD, FACG

Release Date: 1/21/2016

Event: 2015 ACG Annual Meeting

CME Value: 0 minutes

Keywords: IBS, irritable bowel syndrome, probiotics, antibiotics

Diet: Which Should You Choose for Your IBS Patient?

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Assess dietary interventions in IBS using an evidence-based approach.

Presenter: William D. Chey, MD, FACG

Release Date: 1/21/2016

Event: 2015 ACG Annual Meeting

CME Value: 0 minutes

Keywords: irritable bowel syndrome, IBS, therapies, therapy, dietary, diet, evidence-based

When Your Patient Wants a Pill: What Are the New and Upcoming Pharmacologic Options?

Preview Item: view 3 minute preview

Content Type: Presentations

Objective: Outline new treatments for IBS (eluxadoline, plecanatide, elobixibat, linaclotide) and upcoming therapies.

Presenter: Darren M. Brenner, MD

Release Date: 1/21/2016

Event: 2015 ACG Annual Meeting

CME Value: 0 minutes

Keywords: IBS, irritable bowel syndrome, pharmacology, therapy, therapies, treatment